Project Details


In this study, we aim to assess whether low pre-treatment muscle mass, measured with CT at thoracic (T4) or lumbar level (L3) is associated with early termination of chemotherapy related to toxicity in head and neck cancer (HNC) patients.

Layman's description

Relatie tussen spiermassa en vroegtijdig stoppen van chemotherapie bij patienten met hoofd-halskanker
Short titleMuscle mass and tearmination of chemotherapy
Effective start/end date1/01/15 → …

Collaborative partners

  • Hanze University of Applied Sciences
  • Department of Oncology, University of Alberta (lead)
  • Faculty of Medicine, Prince of Songkla University
  • University of Groningen, University Medical Center Groningen, Department of Oral and Maxillofacial Surgery